Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China.
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106151. doi: 10.1016/j.jstrokecerebrovasdis.2021.106151. Epub 2021 Nov 22.
Prior data suggest paternal or sibling stroke was associated with increased risk of offspring stroke. Whether family history of cardiovascular disease (FHc) predicts risk of stroke recurrence remains unclear, we aim to determine this issue on patients with ischemic stroke (IS) or transient ischemic attack (TIA).
This is a post hoc analysis based on the Third China National Stroke Registry III. IS/TIA patients with data of FHc status were included. FHc was defined as family history of coronary heart disease (CHD) or stroke among first-degree relatives (include parents, children, and siblings (same parents)). Cox proportional hazards regression models were performed to assess the association between FHc and recurrent events at 1 year follow-up.
Totally 14,208 patients with verified FHc status were included, 4,454 (31.3%) were female and the median (IQR) age was 62.0 (54.0, 70.0) years. Of these, 294 (2.1%), 726 (5.1%) and 1936 (13.6%) had family history of both CHD and stroke, family history of CHD, and family history of stroke only, respectively. Using multivariable Cox models adjusted for age, sex, and vascular risk factors, we found that patients with FHc experienced higher risk of stroke recurrence (HR=1.151, 95%CI=1.000-1.324) and combined vascular events (HR=1.186, 95%CI=1.036-1.358) at 1 year compared with those without FHc. In sensitivity analysis on patients who received primary secondary prevention treatment of antiplatelet and statins, the association persisted.
FHc is associated with increased risk of stroke recurrence even under primary secondary prevention treatment.
先前的数据表明,父亲或兄弟卒中与后代卒中风险增加相关。家族心血管疾病(FHc)史是否预测卒中复发风险尚不清楚,我们旨在确定缺血性卒中和短暂性脑缺血发作(TIA)患者中的这一问题。
这是基于第三次中国国家卒中登记研究 III 的事后分析。纳入有 FHc 状态数据的 IS/TIA 患者。FHc 定义为一级亲属(包括父母、子女和兄弟姐妹(同一父母))中有冠心病(CHD)或卒中家族史。使用 Cox 比例风险回归模型评估 FHc 与 1 年随访时复发性事件之间的关系。
共纳入 14208 例有 FHc 状态证实的患者,4454 例(31.3%)为女性,中位(IQR)年龄为 62.0(54.0,70.0)岁。其中,294 例(2.1%)、726 例(5.1%)和 1936 例(13.6%)分别有 CHD 和卒中的家族史、CHD 的家族史和卒中的家族史。使用多变量 Cox 模型调整年龄、性别和血管危险因素后,我们发现有 FHc 的患者卒中复发风险更高(HR=1.151,95%CI=1.000-1.324)和复合血管事件(HR=1.186,95%CI=1.036-1.358)在 1 年时与无 FHc 的患者相比。在接受抗血小板和他汀类药物一级和二级预防治疗的患者中进行敏感性分析,该关联仍然存在。
即使在接受一级和二级预防治疗的情况下,FHc 与卒中复发风险增加相关。